Days go by as encorafenib pills await authorization for EC-FOLFOX prescribed last week after #ASCO25. Hoping patient care can proceed without delay and the practice-changing BREAKWATER regimen can be used as it is urgently needed.
Seen on @athaliapyzer's LinkedIn: RFK-pandering advertisement on the way to #ASCO2025 #ASCO25 😡 Sunscreens may not be perfect but Melanoma KILLS. Use whatever SPF you have access to!
One of the things I love about @ASCO annual meetings like #ASCO25 is the opportunity in a short time to connect between academic disciplines and with industry to accelerate progress to help patients. @wallyjc @DrChoueiri Adam Crystal Santosh Gaddam.
People w/ metastatic breast cancer take cancer therapies for the rest of their lives. But the drugs eventually stop working. A new study shows blood tests can alert them when they need to switch therapies. The approach helps them them stay healthier longer. www.nbcnews.com/health/cance... #asco25

'Liquid biopsies' alert advanc...
'Liquid biopsies' alert advanced breast cancer patients when new drugs are needed

New research suggests that blood tests known as “liquid biopsies” can improve the treatment of some people with metastatic breast cancer and help their tumors remain under control for more than a year.

NBC News
Grateful to Dr. Howard Safran for organizing a @BrownUnivHealth Cancer Institute gathering at @jakemelnicks Corner Tap with friends from #LegorretaCancerCenter and @carenewengland at #ASCO25 in Chicago. @CaraMath @HinaKhanMD @DrSGraff @bcarneiro7 @ShiOnaCo
Great to see Drs. @rachnatshroff @uarizona, Charles Blanke @SWOG, and Thomas George @UF at #ASCO25 President’s Reception in Chicago. @ASCO
Great to see Drs. @CliffordHudis and Ed Balaban at #ASCO25 President’s Reception in Chicago. @ASCO
#asco25 | Wafik S. El-Deiry, MD, PhD, FACP

Some networking at #ASCO25 in Chicago today. The Warren Alpert Medical School of Brown University Brown University Health Care New England American Society of Clinical Oncology (ASCO) OncoDaily Benedito A. Carneiro, MD, MS Alex Raufi Tempus AI Caris Life Sciences Novocure Dr. Don S. Dizon Stephanie Graff, MD, FACP, FASCO Jeremy Warner Shiyoko Cothren, MHA, FACHE Liang Cheng Cara Mathews Charles Blanke, MD Lia Tsimberidou Razelle Kurzrock WIN Consortium in cancer personalized medicine Sheba Medical Center, Tel Hashomer Jeff Elton Eric Lefkofsky Mark Ratain Crystal Denlinger Mark Stein Moshe Giladi Ibrahim Abu-Gheida Charles Rudin Amir Onn Jair Bar Sewanti Limaye, MBBS, MD, MS Philip Perez Joanne Xiu, Ph. D. Clifford Hudis Otis Brawley Rachna Shroff, MD, FASCO Eric Winer, MD, FASCO Noumaan Shamsi Robert W. Sobol Jr. Sendurai Mani

“Liquid biopsies” alert people with advanced breast cancer when new treatments stop working, allowing patients to switch to more effective therapies before their tumors grow larger. #asco25 #asco2025 #bcsm www.nbcnews.com/news/amp/rcn...

'Liquid biopsies' alert advanc...
'Liquid biopsies' alert advanced breast cancer patients when new drugs are needed

New research suggests that blood tests known as “liquid biopsies” can improve the treatment of some people with metastatic breast cancer and help their tumors remain under control for more than a year.

NBC News

The future of oncology is precision oncology. The mainstream is realizing this slowly with important advances presented at @ASCO #ASCO25 (BREAKWATER)

Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives

https://www.bloomberg.com/graphics/2025-cancer-treatment-costs/
@angRchen @AngusRChen @WIN_Consortium